|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
decreases expression multiple interactions |
ISO EXP |
Chloroquine results in decreased expression of ABCB1 mRNA; Chloroquine results in decreased expression of ABCB1 protein [Chloroquine co-treated with Bortezomib] results in decreased expression of ABCB1A protein; Bortezomib promotes the reaction [Chloroquine results in decreased expression of ABCB1A mRNA]; Bortezomib promotes the reaction [Chloroquine results in decreased expression of and results in increased nitrosation of ABCB1A protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in decreased expression of ABCB1A protein]; Chloroquine promotes the reaction [Bortezomib results in decreased expression of ABCB1A mRNA]; Chloroquine promotes the reaction [Bortezomib results in decreased expression of and results in increased nitrosation of ABCB1A protein]; Chloroquine results in decreased expression of and results in increased nitrosation of ABCB1A protein; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in decreased expression of ABCB1A protein]] Bortezomib promotes the reaction [Chloroquine results in decreased expression of ABCB1 mRNA]; Bortezomib promotes the reaction [Chloroquine results in decreased expression of and results in increased nitrosation of ABCB1 protein]; Chloroquine promotes the reaction [Bortezomib results in decreased expression of ABCB1 mRNA]; Chloroquine promotes the reaction [Bortezomib results in decreased expression of and results in increased nitrosation of ABCB1 protein]; Chloroquine promotes the reaction [Cisplatin results in decreased expression of ABCB1 mRNA]; Chloroquine promotes the reaction [Cisplatin results in decreased expression of ABCB1 protein]; Chloroquine results in decreased expression of and results in increased nitrosation of ABCB1 protein |
CTD |
PMID:25987058 PMID:27692344 PMID:30482226 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of ABCC1 mRNA; Chloroquine results in decreased expression of ABCC1 protein |
CTD |
PMID:27692344 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
decreases expression |
ISO |
Chloroquine results in decreased expression of ABCC2 mRNA; Chloroquine results in decreased expression of ABCC2 protein |
CTD |
PMID:27692344 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
decreases expression |
ISO |
Chloroquine results in decreased expression of ABCG2 mRNA; Chloroquine results in decreased expression of ABCG2 protein |
CTD |
PMID:27692344 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Chloroquine promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; Chloroquine promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein] |
CTD |
PMID:33070465 |
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Particulate Matter results in increased expression of ACSL4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr X:141,100,989...141,173,792
Ensembl chr X:141,100,989...141,173,531
|
|
G |
Acta2 |
actin alpha 2, smooth muscle, aorta |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of ACTA2 protein]] |
CTD |
PMID:35104487 |
|
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions decreases phosphorylation |
ISO |
Chloroquine affects the reaction [Cannabidiol results in decreased phosphorylation of AKT1 protein]; Chloroquine inhibits the reaction [formosanin C results in decreased phosphorylation of AKT1 protein] Chloroquine inhibits the reaction [[Diethylnitrosamine co-treated with N-nitrosomorpholine] results in increased expression of and results in increased phosphorylation of AKT1 protein] Chloroquine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:24990399 PMID:27180204 PMID:32060308 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein] |
CTD |
PMID:22689575 |
|
NCBI chr 7:44,498,648...44,504,845
Ensembl chr 7:44,498,415...44,504,845
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
|
|
G |
Angptl8 |
angiopoietin-like 8 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [ANGPTL8 protein results in decreased expression of SQSTM1 protein] |
CTD |
PMID:24262987 |
|
NCBI chr 9:21,746,806...21,748,643
Ensembl chr 9:21,746,806...21,748,643
|
|
G |
Apod |
apolipoprotein D |
affects localization |
ISO |
Chloroquine affects the localization of APOD protein |
CTD |
PMID:28182653 |
|
NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626
|
|
G |
Apoe |
apolipoprotein E |
affects localization |
ISO |
Chloroquine affects the localization of APOE protein |
CTD |
PMID:8616629 |
|
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
|
|
G |
App |
amyloid beta precursor protein |
affects expression increases expression affects localization multiple interactions |
ISO |
Chloroquine affects the expression of APP mRNA; Chloroquine affects the expression of APP protein Chloroquine results in increased expression of APP protein Chloroquine affects the localization of APP protein Chloroquine affects the localization of and affects the cleavage of APP protein |
CTD |
PMID:7715800 PMID:8616629 PMID:8787835 PMID:9690670 |
|
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Lipopolysaccharides results in increased degradation of APPL1 protein]; Chloroquine inhibits the reaction [Poly I-C results in increased degradation of APPL1 protein] |
CTD |
PMID:25780039 |
|
NCBI chr14:26,640,943...26,692,567
Ensembl chr14:26,640,945...26,693,189
|
|
G |
Aqp2 |
aquaporin 2 |
decreases degradation decreases expression multiple interactions |
EXP ISO |
Chloroquine results in decreased degradation of AQP2 protein Chloroquine results in decreased expression of AQP2 protein Chloroquine inhibits the reaction [AVP protein affects the localization of AQP2 protein] |
CTD |
PMID:21734099 PMID:22791344 |
|
NCBI chr15:99,476,937...99,482,426
Ensembl chr15:99,476,936...99,482,428
|
|
G |
Aqp5 |
aquaporin 5 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Cyclic AMP results in decreased expression of AQP5 protein] |
CTD |
PMID:15536076 |
|
NCBI chr15:99,488,909...99,492,710
Ensembl chr15:99,488,663...99,492,710
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Riluzole results in increased degradation of and results in decreased expression of AR protein alternative form]; Chloroquine inhibits the reaction [Riluzole results in increased degradation of and results in decreased expression of AR protein] |
CTD |
PMID:30280407 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arcn1 |
archain 1 |
affects localization |
ISO |
Chloroquine affects the localization of ARCN1 protein |
CTD |
PMID:29940786 |
|
NCBI chr 9:44,653,440...44,679,105
Ensembl chr 9:44,652,861...44,679,142
|
|
G |
Ass1 |
argininosuccinate synthetase 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of ASS1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [cadmium acetate results in increased expression of ATF4 protein] |
CTD |
PMID:29870746 |
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases expression |
ISO |
Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of ATG5 protein] Chloroquine results in increased expression of ATG5 protein Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] |
CTD |
PMID:28184909 PMID:29870746 PMID:30338810 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Atm |
ataxia telangiectasia mutated |
increases phosphorylation |
ISO |
Chloroquine results in increased phosphorylation of ATM protein |
CTD |
PMID:18089834 |
|
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
multiple interactions increases expression |
ISO |
Chloroquine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP1A1 protein] Chloroquine results in increased expression of ATP1A1 protein |
CTD |
PMID:10506578 PMID:26750564 |
|
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [AVP protein affects the localization of AQP2 protein]; Chloroquine inhibits the reaction [AVP protein affects the localization of SLC14A2 protein] |
CTD |
PMID:22791344 |
|
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
EXP ISO |
BAX mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein]; Chloroquine promotes the reaction [triethylene glycol dimethacrylate results in increased expression of BAX protein] Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of BAX protein]] Chloroquine affects the folding of and results in increased activity of BAX protein; Chloroquine inhibits the reaction [formosanin C results in increased expression of BAX protein]; Chloroquine promotes the reaction [dactolisib affects the folding of and results in increased activity of BAX protein]; dactolisib promotes the reaction [Chloroquine affects the folding of and results in increased activity of BAX protein] |
CTD |
PMID:11589424 PMID:23151917 PMID:27180204 PMID:28713934 PMID:33684387 PMID:35104487 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bbc3 |
BCL2 binding component 3 |
increases expression |
EXP |
Chloroquine results in increased expression of BBC3 mRNA |
CTD |
PMID:31310755 |
|
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [formosanin C results in decreased expression of BCL2 protein] Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]] |
CTD |
PMID:27180204 PMID:28713934 PMID:35104487 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions increases expression |
EXP |
BCL2L1 mutant form promotes the reaction [Chloroquine results in increased activity of CASP3 protein] Chloroquine results in increased expression of BCL2L1 mRNA |
CTD |
PMID:11589424 PMID:31310755 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Becn1 |
beclin 1, autophagy related |
multiple interactions decreases expression |
ISO EXP |
Carboplatin promotes the reaction [Chloroquine results in decreased expression of BECN1 protein]; Chloroquine inhibits the reaction [Cannabidiol results in increased expression of BECN1 protein]; Chloroquine inhibits the reaction [Cisplatin results in increased expression of BECN1 protein]; Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of BECN1 protein]; Chloroquine promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; Chloroquine promotes the reaction [Carboplatin results in decreased expression of BECN1 protein]; Chloroquine promotes the reaction [XPO1 protein binds to BECN1 protein] Chloroquine inhibits the reaction [Cadmium Chloride results in increased expression of BECN1 mRNA]; Chloroquine promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BECN1 protein] Chloroquine inhibits the reaction [cadmium acetate results in increased expression of BECN1 protein]; Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of BECN1 protein]] Chloroquine results in decreased expression of BECN1 mRNA; Chloroquine results in decreased expression of BECN1 protein |
CTD |
PMID:25987058 PMID:27692344 PMID:28184909 PMID:29870746 PMID:31862506 PMID:32060308 PMID:33070465 PMID:35104487 PMID:35843418 More...
|
|
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
|
|
G |
Bglap |
bone gamma carboxyglutamate protein |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA] |
CTD |
PMID:23111315 |
|
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
EXP ISO |
Chloroquine promotes the reaction [sunitinib results in decreased expression of BIRC5 protein] Chloroquine promotes the reaction [Immunologic Factors results in decreased expression of BIRC5 protein] |
CTD |
PMID:24751611 PMID:27823620 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
increases expression multiple interactions |
ISO |
Chloroquine results in increased expression of BNIP3 protein vistusertib inhibits the reaction [Chloroquine results in increased expression of BNIP3 protein] |
CTD |
PMID:26853465 |
|
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
Btrc |
beta-transducin repeat containing protein |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]; Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax] results in decreased expression of BTRC mRNA]; Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax] results in decreased expression of BTRC protein] |
CTD |
PMID:35561756 |
|
NCBI chr19:45,352,119...45,521,782
Ensembl chr19:45,352,173...45,518,452
|
|
G |
Calr |
calreticulin |
multiple interactions increases expression |
EXP ISO |
[Chloroquine co-treated with Bortezomib] results in increased expression of CALR protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR protein]] Chloroquine results in increased expression of CALR mRNA [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of and affects the localization of CALR protein]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CALR mRNA]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [Chloroquine results in increased expression of and affects the localization of CALR protein]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [Chloroquine results in increased expression of CALR mRNA]; [Chloroquine co-treated with Bortezomib] promotes the reaction [CEBPB protein alternative form binds to CALR promoter]; [Chloroquine co-treated with Bortezomib] results in increased expression of and affects the localization of CALR protein; [Chloroquine co-treated with Bortezomib] results in increased expression of CALR mRNA; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of and affects the localization of CALR protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR mRNA]; CEBPB protein alternative form promotes the reaction [Chloroquine results in increased expression of and affects the localization of CALR protein]; CEBPB protein alternative form promotes the reaction [Chloroquine results in increased expression of CALR mRNA]; Chloroquine promotes the reaction [CEBPB protein alternative form binds to CALR promoter]; Chloroquine results in increased expression of and affects the localization of CALR protein; DDIT3 protein affects the reaction [[Chloroquine co-treated with Bortezomib] affects the localization of CALR protein]; DDIT3 protein affects the reaction [Chloroquine affects the localization of CALR protein]; Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] affects the localization of CALR protein]; Doxorubicin promotes the reaction [Chloroquine affects the localization of CALR protein] |
CTD |
PMID:30482226 |
|
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [cadmium acetate results in increased expression of CASP12 protein] |
CTD |
PMID:29870746 |
|
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases expression increases activity |
EXP ISO |
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Chloroquine results in increased cleavage of CASP3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased cleavage of CASP3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased cleavage of CASP3 protein]; [Bortezomib co-treated with Chloroquine] results in increased cleavage of CASP3 protein; [Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein; [Rotenone co-treated with Chloroquine] results in increased cleavage of CASP3 protein; BAX mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein]; BCL2L1 mutant form promotes the reaction [Chloroquine results in increased activity of CASP3 protein]; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]]; Chloroquine promotes the reaction [Cisplatin results in increased expression of CASP3 protein modified form]; Chloroquine promotes the reaction [Sunitinib results in increased activity of CASP3 protein]; Chloroquine promotes the reaction [triethylene glycol dimethacrylate results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]]; Doxorubicin promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; TRP53 mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein] Chloroquine inhibits the reaction [3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; Chloroquine inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]]; Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of CASP3 protein]]; Chloroquine promotes the reaction [Methamphetamine results in increased cleavage of CASP3 protein] Chloroquine results in increased expression of CASP3 protein 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Chloroquine results in increased cleavage of CASP3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased cleavage of CASP3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased cleavage of CASP3 protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [[vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein]; [Bortezomib co-treated with Chloroquine] results in increased cleavage of CASP3 protein; [capivasertib co-treated with Chloroquine] results in increased activity of CASP3 protein; [Chloroquine co-treated with vandetanib] results in increased activity of CASP3 protein; [vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; CA 074 methyl ester inhibits the reaction [[capivasertib co-treated with Chloroquine] results in increased activity of CASP3 protein]; CA 074 methyl ester inhibits the reaction [[vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein]; Chloroquine inhibits the reaction [alpinetin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]]; Chloroquine inhibits the reaction [betulin results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [Biological Products results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [Cannabidiol results in increased cleavage of CASP3 protein]; Chloroquine inhibits the reaction [formosanin C results in increased expression of and results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [Amiodarone results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [Biological Products results in increased expression of and results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [Cisplatin results in increased expression of CASP3 protein]; Chloroquine promotes the reaction [dactolisib results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [SC-66 compound results in increased cleavage of CASP3 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP3 protein]; dactolisib promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; DDIT3 protein affects the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; DDIT3 protein affects the reaction [Chloroquine results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein]; NDRG1 protein affects the reaction [Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of CASP3 protein]]; NDRG1 protein affects the reaction [Chloroquine results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased cleavage of CASP3 protein] |
CTD |
PMID:11589424 PMID:23151917 PMID:23799852 PMID:24751611 PMID:25078063 PMID:25266202 PMID:25987058 PMID:26847702 PMID:26853465 PMID:27180204 PMID:28219700 PMID:28906492 PMID:29111403 PMID:29476062 PMID:30338810 PMID:30465897 PMID:30482226 PMID:30985881 PMID:31332898 PMID:31676321 PMID:32060308 PMID:32190974 PMID:32651653 PMID:33684387 PMID:34374793 PMID:35104487 PMID:37741534 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [usnic acid results in increased activity of CASP7 protein] |
CTD |
PMID:25078063 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases cleavage multiple interactions |
ISO EXP |
Chloroquine results in increased cleavage of CASP8 protein Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of CASP8 protein] Chloroquine inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] |
CTD |
PMID:27692344 PMID:28906492 PMID:29111403 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
[Chloroquine co-treated with vandetanib] results in increased activity of CASP9 protein; Chloroquine inhibits the reaction [Cannabidiol results in increased cleavage of CASP9 protein]; Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA]; Chloroquine promotes the reaction [dactolisib results in increased cleavage of CASP9 protein]; Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of CASP9 protein]; dactolisib promotes the reaction [Chloroquine results in increased cleavage of CASP9 protein] |
CTD |
PMID:23151917 PMID:23799852 PMID:28184909 PMID:28906492 PMID:32060308 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Casr |
calcium-sensing receptor |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR mRNA]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR protein] |
CTD |
PMID:32956540 |
|
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
|
|
G |
Cat |
catalase |
decreases activity multiple interactions decreases expression |
ISO EXP |
Chloroquine results in decreased activity of CAT protein Chloroquine promotes the reaction [Sunitinib results in increased activity of CAT protein]; Quercetin inhibits the reaction [Chloroquine results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Chloroquine results in decreased expression of CAT mRNA] Curcumin inhibits the reaction [Chloroquine results in decreased activity of CAT protein]; tetrahydrocurcumin inhibits the reaction [Chloroquine results in decreased activity of CAT protein] Chloroquine results in decreased expression of CAT protein |
CTD |
PMID:15526909 PMID:17076682 PMID:23607047 PMID:24751611 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL1 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
decreases secretion multiple interactions |
ISO EXP |
Chloroquine results in decreased secretion of CCL11 protein Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL11 protein] |
CTD |
PMID:22341560 PMID:29772762 |
|
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions decreases secretion |
ISO EXP |
Chloroquine results in increased expression of CCL2 mRNA Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein] Chloroquine results in decreased secretion of CCL2 protein Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax] results in decreased expression of MCP1 protein]; diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] |
CTD |
PMID:15139008 PMID:22341560 PMID:29772762 PMID:35561756 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl25 |
C-C motif chemokine ligand 25 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL25 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 8:4,375,207...4,410,020
Ensembl chr 8:4,375,210...4,410,020
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL5 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL9 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression multiple interactions |
ISO |
Chloroquine results in increased expression of CCN1 mRNA Chloroquine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]] |
CTD |
PMID:19393257 PMID:34405320 |
|
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
|
|
G |
Cd274 |
CD274 antigen |
decreases expression |
ISO |
Chloroquine results in decreased expression of CD274 protein |
CTD |
PMID:27692344 |
|
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
|
|
G |
Cd34 |
CD34 antigen |
multiple interactions |
EXP |
Chloroquine promotes the reaction [sunitinib results in decreased expression of CD34 protein] |
CTD |
PMID:24751611 |
|
NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Chloroquine inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein] |
CTD |
PMID:30053495 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CDH2 mRNA]; Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CDH2 protein] |
CTD |
PMID:30053495 |
|
NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
increases activity multiple interactions increases expression |
ISO |
Chloroquine results in increased activity of CDKN1A [Chloroquine co-treated with flavokawain B] results in decreased expression of CDKN1A protein; Chloroquine inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] Chloroquine results in increased expression of CDKN1A protein |
CTD |
PMID:12243503 PMID:18089834 PMID:22927544 PMID:30025493 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of CDKN2A protein]] |
CTD |
PMID:36792013 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
EXP ISO |
Chloroquine results in increased expression of CEBPB protein alternative form 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CEBPB protein alternative form]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CEBPB protein alternative form]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased expression of CEBPB protein alternative form]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of and affects the localization of CALR protein]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CALR mRNA]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [Chloroquine results in increased expression of and affects the localization of CALR protein]; [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [Chloroquine results in increased expression of CALR mRNA]; [Chloroquine co-treated with Bortezomib] promotes the reaction [CEBPB protein alternative form binds to CALR promoter]; [Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of and affects the localization of CALR protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR mRNA]; CEBPB protein alternative form promotes the reaction [Chloroquine results in increased expression of and affects the localization of CALR protein]; CEBPB protein alternative form promotes the reaction [Chloroquine results in increased expression of CALR mRNA]; Chloroquine promotes the reaction [CEBPB protein alternative form binds to CALR promoter]; Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of CEBPB protein alternative form] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of CEBPB protein alternative form]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased expression of CEBPB protein alternative form]; [Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in decreased expression of ABCB1A protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of IFNG protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in decreased expression of ABCB1A protein]]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CALR protein]]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of IFNG protein]]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of CEBPB protein alternative form] |
CTD |
PMID:30482226 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
decreases expression |
ISO |
Chloroquine results in decreased expression of CHUK protein |
CTD |
PMID:26116531 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Cip2a |
cell proliferation regulating inhibitor of protein phosphatase 2A |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [temsirolimus results in decreased expression of CIP2A protein] |
CTD |
PMID:24493623 |
|
NCBI chr16:48,814,524...48,840,079
Ensembl chr16:48,814,548...48,840,072
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
ISO |
Chloroquine results in increased expression of CLDN1 mRNA |
CTD |
PMID:25752684 |
|
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [caffeic acid phenethyl ester results in decreased expression of CLDN2 protein] |
CTD |
PMID:29597147 |
|
NCBI chr X:138,701,552...138,712,135
Ensembl chr X:138,701,577...138,712,135
|
|
G |
Clu |
clusterin |
affects localization |
ISO |
Chloroquine affects the localization of CLU protein |
CTD |
PMID:8616629 |
|
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
decreases expression |
ISO |
Chloroquine results in decreased expression of COQ6 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr12:84,408,530...84,420,570
Ensembl chr12:84,408,431...84,420,570
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4I1 |
multiple interactions |
EXP |
Chloroquine promotes the reaction [Triiodothyronine results in increased expression of COX4I1 protein] |
CTD |
PMID:30209975 |
|
NCBI chr 8:121,394,964...121,400,948
Ensembl chr 8:121,394,961...121,400,946
|
|
G |
Cs |
citrate synthase |
multiple interactions |
EXP |
Chloroquine affects the reaction [triethylene glycol dimethacrylate affects the activity of CS protein] |
CTD |
PMID:33684387 |
|
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:30053495 |
|
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
|
|
G |
Ctrl |
chymotrypsin-like |
decreases expression |
ISO |
Chloroquine results in decreased expression of CTRB1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 8:106,658,626...106,660,494
Ensembl chr 8:106,658,635...106,660,494
|
|
G |
Ctsa |
cathepsin A |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of CTSA protein |
CTD |
PMID:30821613 |
|
NCBI chr 2:164,674,792...164,682,952
Ensembl chr 2:164,674,793...164,682,952
|
|
G |
Ctsb |
cathepsin B |
increases expression multiple interactions decreases activity |
ISO EXP |
Chloroquine results in increased expression of CTSB protein Chloroquine promotes the reaction [Arsenic results in increased activity of CTSB protein] Chloroquine results in decreased activity of CTSB protein [Chloroquine co-treated with dactolisib] affects the localization of CTSB protein; [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of CTSB protein; Chloroquine inhibits the reaction [Arsenic Trioxide results in increased activity of CTSB protein] |
CTD |
PMID:2759144 PMID:23151917 PMID:30338810 PMID:30821613 PMID:36117518 |
|
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Ctsd |
cathepsin D |
affects localization multiple interactions increases expression |
ISO |
Chloroquine affects the localization of CTSD protein [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of CTSD protein Chloroquine results in increased expression of CTSD protein |
CTD |
PMID:2759144 PMID:7715800 PMID:30821613 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Cadmium Chloride results in increased expression of CTSK mRNA]; Chloroquine inhibits the reaction [Cadmium Chloride results in increased expression of CTSK protein] |
CTD |
PMID:35843418 |
|
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
|
|
G |
Ctsl |
cathepsin L |
increases expression |
ISO |
Chloroquine results in increased expression of CTSL protein |
CTD |
PMID:2759144 |
|
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [CpG ODN 2216 results in increased expression of CXCL10 protein]; Chloroquine inhibits the reaction [gardiquimod results in increased expression of CXCL10 protein]; Chloroquine inhibits the reaction [Poly I-C results in increased expression of CXCL10 protein] |
CTD |
PMID:26682054 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CXCL12 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions increases expression |
ISO EXP |
[Chloroquine co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA; Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CXCL8 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Chloroquine results in increased expression of CXCL8 mRNA]; Chloroquine inhibits the reaction [SSB protein results in increased expression of CXCL8 mRNA]; Chloroquine inhibits the reaction [SSB protein results in increased secretion of CXCL8 protein]; diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CXCL8 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Chloroquine results in increased expression of CXCL8 mRNA] Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of CXCL8] |
CTD |
PMID:15139008 PMID:22595112 PMID:25915936 PMID:29594315 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CXCL9 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine] |
CTD |
PMID:7946932 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
affects metabolic processing multiple interactions increases metabolic processing |
ISO |
CYP2C8 polymorphism affects the metabolism of Chloroquine; CYP2C8 protein affects the metabolism of Chloroquine [CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine; Quercetin inhibits the reaction [[CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine] |
CTD |
PMID:12756207 PMID:12920490 PMID:12967198 PMID:17286541 PMID:19560616 |
|
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
affects metabolic processing decreases activity multiple interactions |
ISO |
CYP2D6 protein affects the metabolism of Chloroquine Chloroquine results in decreased activity of CYP2D6 protein [CYP2D6 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine |
CTD |
PMID:12756207 PMID:12920490 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form]; CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:28275691 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO EXP |
Chloroquine promotes the reaction [cadmium acetate results in increased expression of DDIT3 protein]; Chloroquine promotes the reaction [Cadmium results in increased expression of DDIT3 protein] Chloroquine results in increased expression of DDIT3 protein 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased expression of DDIT3 protein]; [Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; DDIT3 protein affects the reaction [[Chloroquine co-treated with Bortezomib] affects the localization of CALR protein]; DDIT3 protein affects the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; DDIT3 protein affects the reaction [Chloroquine affects the localization of CALR protein]; DDIT3 protein affects the reaction [Chloroquine results in increased cleavage of CASP3 protein]; Doxorubicin promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of DDIT3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased expression of DDIT3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased expression of DDIT3 protein]; [Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein; [Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Doxorubicin promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of DDIT3 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of DDIT3 protein]; Nitroprusside inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Nitroprusside inhibits the reaction [Chloroquine results in increased expression of DDIT3 protein] |
CTD |
PMID:27658547 PMID:29870746 PMID:30482226 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddx3x |
DEAD box helicase 3, X-linked |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of DDX3X protein; Chloroquine inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of DDX3X protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of DDX3X protein] |
CTD |
PMID:30821613 |
|
NCBI chr X:13,147,261...13,160,222
Ensembl chr X:13,147,209...13,160,291
|
|
G |
Eea1 |
early endosome antigen 1 |
affects localization |
ISO |
Chloroquine affects the localization of EEA1 protein |
CTD |
PMID:29940786 |
|
NCBI chr10:95,776,525...95,881,380
Ensembl chr10:95,776,512...95,881,380
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [EGF protein results in decreased expression of EGFR protein] Chloroquine inhibits the reaction [EGF protein results in increased expression of RHEB protein]; Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of EIF4EBP1 protein]; Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein]; Chloroquine promotes the reaction [EGF protein results in increased expression of and results in increased phosphorylation of EGFR protein] |
CTD |
PMID:20332299 PMID:22689575 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [EGF protein results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [MUC1 affects the expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfide results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfone results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [tephrosin results in increased degradation of EGFR protein] Chloroquine promotes the reaction [EGF protein results in increased expression of and results in increased phosphorylation of EGFR protein] Chloroquine results in decreased expression of EGFR protein |
CTD |
PMID:20056314 PMID:20332299 PMID:22457794 PMID:22689575 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4A1 protein; Chloroquine inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4A1 protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4A1 protein] |
CTD |
PMID:30821613 |
|
NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:22689575 |
|
NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
|
|
G |
Eif4h |
eukaryotic translation initiation factor 4H |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4H protein; Chloroquine inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4H protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4H protein] |
CTD |
PMID:30821613 |
|
NCBI chr 5:134,648,726...134,668,263
Ensembl chr 5:134,648,575...134,668,344
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Sirolimus results in increased expression of ENO2 protein] |
CTD |
PMID:26676567 |
|
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
decreases expression multiple interactions |
ISO |
Chloroquine results in decreased expression of ERBB2 protein Chloroquine inhibits the reaction [tephrosin results in increased degradation of ERBB2 protein] |
CTD |
PMID:20056314 PMID:20332299 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
Chloroquine results in decreased expression of ERBB3 protein |
CTD |
PMID:20332299 |
|
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
multiple interactions |
ISO |
ERGIC3 protein promotes the reaction [Chloroquine results in increased expression of SQSTM1 protein] |
CTD |
PMID:27588471 |
|
NCBI chr 2:155,849,948...155,860,199
Ensembl chr 2:155,849,965...155,860,199
|
|
G |
Eva1a |
eva-1 homolog A, regulator of programmed cell death |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of and results in increased degradation of EVA1A protein] |
CTD |
PMID:36078115 |
|
NCBI chr 6:82,018,058...82,070,079
Ensembl chr 6:82,018,024...82,070,080
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
ISO |
Chloroquine results in decreased expression of FADS2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
|
|
G |
Fasl |
Fas ligand |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FASL protein] |
CTD |
PMID:22341560 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fbxo32 |
F-box protein 32 |
affects expression |
ISO |
Chloroquine affects the expression of FBXO32 mRNA |
CTD |
PMID:19296457 |
|
NCBI chr15:58,039,275...58,078,288
Ensembl chr15:58,039,275...58,078,328
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in decreased expression of FGF1 mRNA]] |
CTD |
PMID:31332898 |
|
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
|
|
G |
Fmn1 |
formin 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of FMN1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 2:113,158,029...113,547,113
Ensembl chr 2:113,158,081...113,547,112
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [dorsomorphin results in decreased expression of FOXP3 mRNA]; Chloroquine inhibits the reaction [dorsomorphin results in decreased expression of FOXP3 protein] |
CTD |
PMID:31900833 |
|
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
multiple interactions increases expression |
ISO |
Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA] Chloroquine promotes the reaction [erastin results in increased expression of FTH1 protein] Chloroquine results in increased expression of FTH1 mRNA |
CTD |
PMID:30551460 PMID:32937103 PMID:37951334 |
|
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
multiple interactions |
ISO |
Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein] |
CTD |
PMID:37951334 |
|
NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
|
|
G |
Fundc1 |
FUN14 domain containing 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Rotenone results in decreased expression of FUNDC1 protein] |
CTD |
PMID:32001317 PMID:37156403 |
|
NCBI chr X:17,386,206...17,438,600
Ensembl chr X:17,422,803...17,438,564
|
|
G |
Gabarapl2 |
GABA type A receptor associated protein like 2 |
increases expression |
ISO |
Chloroquine results in increased expression of GABARAPL2 protein |
CTD |
PMID:36482696 |
|
NCBI chr 8:112,667,335...112,679,547
Ensembl chr 8:112,667,335...112,680,244
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
multiple interactions |
ISO |
GAL3ST1 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:23880069 |
|
NCBI chr11:3,933,636...3,949,328
Ensembl chr11:3,933,636...3,949,326
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO EXP |
Chloroquine inhibits the reaction [DDT results in increased degradation of GJA1 protein modified form]; Chloroquine inhibits the reaction [Hexachlorocyclohexane results in increased degradation of GJA1 protein modified form]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of GJA1 protein] Chloroquine inhibits the reaction [LAMB1 protein affects the localization of GJA1 protein] |
CTD |
PMID:8824497 PMID:22150760 PMID:28713934 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases expression |
ISO |
Chloroquine results in decreased expression of GJB2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
ISO EXP |
[Chloroquine co-treated with flavokawain B] results in decreased expression of GLB1 protein Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of GLB1 protein]] |
CTD |
PMID:30025493 PMID:36792013 |
|
NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Oleic Acid results in increased degradation of and results in decreased expression of GLP1R protein] |
CTD |
PMID:22925809 |
|
NCBI chr17:31,120,841...31,155,484
Ensembl chr17:31,120,791...31,159,765
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
ISO |
Chloroquine results in decreased expression of GLUL protein |
CTD |
PMID:36482696 |
|
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
|
|
G |
Golga2 |
golgin A2 |
affects localization |
ISO |
Chloroquine affects the localization of GOLGA2 protein |
CTD |
PMID:29940786 |
|
NCBI chr 2:32,178,299...32,197,925
Ensembl chr 2:32,177,396...32,197,933
|
|
G |
Gpnmb |
glycoprotein (transmembrane) nmb |
increases expression |
ISO |
Chloroquine results in increased expression of GPNMB mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
|
|
G |
Gpr182 |
G protein-coupled receptor 182 |
decreases expression |
ISO |
Chloroquine results in decreased expression of GPR182 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr10:127,585,471...127,587,667
Ensembl chr10:127,583,145...127,587,601
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
EXP ISO |
Chloroquine inhibits the reaction [coenzyme Q10 inhibits the reaction [Acetaminophen results in increased activity of GPT protein]]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased activity of GPT protein]]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased activity of GPT protein]; Chloroquine promotes the reaction [Acetaminophen results in increased activity of GPT protein] [Chloroquine co-treated with Clozapine] results in increased secretion of GPT protein |
CTD |
PMID:26498332 PMID:33271250 PMID:36482696 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
EXP ISO |
Chloroquine results in decreased expression of GPX4 mRNA Chloroquine inhibits the reaction [Particulate Matter results in decreased expression of GPX4 protein] Chloroquine inhibits the reaction [Cisplatin results in decreased expression of GPX4 protein]; Quercetin inhibits the reaction [Chloroquine results in decreased expression of GPX4 mRNA] |
CTD |
PMID:23607047 PMID:34302894 PMID:36700298 |
|
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
|
|
G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Nanotubes, Carbon results in decreased expression of GRIN2B] |
CTD |
PMID:26327526 |
|
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
Chloroquine promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with sodium arsenite] results in increased expression of and results in increased cleavage of GSDMD protein] |
CTD |
PMID:34920032 |
|
NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
|
|
G |
Gsr |
glutathione reductase |
decreases activity decreases expression multiple interactions |
EXP |
Chloroquine results in decreased activity of GSR protein Chloroquine results in decreased expression of GSR mRNA Quercetin inhibits the reaction [Chloroquine results in decreased activity of GSR protein]; Quercetin inhibits the reaction [Chloroquine results in decreased expression of GSR mRNA] |
CTD |
PMID:23607047 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Hbb-bh1 |
hemoglobin Z, beta-like embryonic chain |
decreases expression |
ISO |
Chloroquine results in decreased expression of HBG1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 7:103,490,845...103,492,369
Ensembl chr 7:103,490,844...103,492,371
|
|
G |
Hdac6 |
histone deacetylase 6 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in increased expression of HDAC6 protein]] |
CTD |
PMID:35104487 |
|
NCBI chr X:7,796,355...7,814,284
Ensembl chr X:7,796,359...7,814,128
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
decreases expression |
ISO |
Chloroquine results in decreased expression of HIF1A protein |
CTD |
PMID:32060308 |
|
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of HK2 protein; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of HK2 protein] |
CTD |
PMID:30821613 |
|
NCBI chr 6:82,702,004...82,751,437
Ensembl chr 6:82,702,006...82,751,435
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
increases response to substance |
ISO |
HMBS mutant form results in increased susceptibility to Chloroquine |
CTD |
PMID:8772850 |
|
NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
|
|
G |
Hspa1b |
heat shock protein 1B |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of HSPA1B protein] |
CTD |
PMID:17046822 |
|
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [cadmium acetate results in increased expression of HSPA5 protein] |
CTD |
PMID:29870746 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspa8 |
heat shock protein 8 |
multiple interactions |
ISO EXP |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of HSPA8 protein alternative form Chloroquine inhibits the reaction [Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]] |
CTD |
PMID:30821613 PMID:36535314 |
|
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]] |
CTD |
PMID:24145604 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 mRNA]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 protein]] |
CTD |
PMID:28134560 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO EXP |
[Chloroquine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA [Chloroquine co-treated with Bortezomib] results in increased expression of IFNG protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of IFNG protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IFNG protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of IFNG protein]] |
CTD |
PMID:22341560 PMID:29594315 PMID:30482226 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
multiple interactions |
ISO |
[Chloroquine co-treated with Berberine] results in decreased expression of IGF2BP3 protein |
CTD |
PMID:36822301 |
|
NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891
|
|
G |
Ikbkb |
inhibitor of kappaB kinase beta |
decreases expression |
ISO |
Chloroquine results in decreased expression of IKBKB protein |
CTD |
PMID:26116531 |
|
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
|
|
G |
Ikbkg |
inhibitor of kappaB kinase gamma |
decreases expression |
ISO |
Chloroquine results in decreased expression of IKBKG protein |
CTD |
PMID:26116531 |
|
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL10 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL13 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Imiquimod results in increased expression of IL17A protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL17A protein] |
CTD |
PMID:22341560 PMID:36002070 |
|
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with sodium arsenite] results in increased expression of IL18 protein] |
CTD |
PMID:34920032 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression multiple interactions |
ISO EXP |
Chloroquine results in increased expression of IL1A Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1A protein] |
CTD |
PMID:15139008 PMID:22341560 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
increases expression decreases expression multiple interactions |
ISO EXP |
Chloroquine results in increased expression of IL1B Chloroquine results in decreased expression of IL1B mRNA Chloroquine inhibits the reaction [Imiquimod results in increased expression of IL1B protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B protein]]; Chloroquine inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B mRNA]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL1B protein] Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]]; Chloroquine inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]; Chloroquine promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with sodium arsenite] results in increased expression of IL1B protein] |
CTD |
PMID:15139008 PMID:21051542 PMID:22341560 PMID:26498332 PMID:29594315 PMID:31648047 PMID:34920032 PMID:36002070 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il2 |
interleukin 2 |
decreases expression multiple interactions |
ISO EXP |
Chloroquine results in decreased expression of IL2 mRNA; Chloroquine results in decreased expression of IL2 protein Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL2 protein] [Chloroquine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:7554381 PMID:22341560 PMID:29594315 |
|
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il3 |
interleukin 3 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL3 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL4 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions decreases secretion increases expression |
ISO EXP |
Chloroquine results in decreased expression of IL6 protein Chloroquine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased expression of IL6 mRNA]] Chloroquine results in decreased secretion of IL6 protein Chloroquine inhibits the reaction [3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased secretion of IL6 protein]] [Chloroquine co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL6 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Chloroquine co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL6 protein]; Bortezomib inhibits the reaction [[Chloroquine co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL6 protein]; Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased secretion of IL6 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 protein]]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 mRNA]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of IL6 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]] Chloroquine results in increased expression of IL6 |
CTD |
PMID:9002011 PMID:9799232 PMID:10638776 PMID:15139008 PMID:22341560 PMID:26498332 PMID:28134560 PMID:29772762 PMID:31332898 PMID:31648047 More...
|
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of IRF3 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased degradation of IRF3 protein]; Chloroquine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]; Chloroquine inhibits the reaction [Poly I-C results in increased phosphorylation of IRF3 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of IRF3 protein]] |
CTD |
PMID:22341560 PMID:25780039 PMID:28134560 |
|
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Itgam |
integrin alpha M |
multiple interactions |
ISO |
[benzyloxycarbonyl-valyl-alanyl-aspartic acid analog co-treated with Chloroquine] inhibits the reaction [Tretinoin affects the localization of ITGAM protein]; Chloroquine inhibits the reaction [Tretinoin affects the localization of ITGAM protein] |
CTD |
PMID:29743969 |
|
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
|
|
G |
Jak2 |
Janus kinase 2 |
decreases phosphorylation |
ISO |
chloroquine co-treated with anlotinib decreases phosphorylation of JAK2 protein in lung epithelium |
RGD |
PMID:30755242 |
RGD:149735343 |
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Lamb1 |
laminin B1 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [LAMB1 protein affects the localization of GJA1 protein] |
CTD |
PMID:22150760 |
|
NCBI chr12:31,315,230...31,379,643
Ensembl chr12:31,315,233...31,379,643
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions |
ISO |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of LAMP2 protein; [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of LAMP2 protein alternative form; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of DDX3X protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4A1 protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of EIF4H protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of HK2 protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of LAMP2 protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of NFKBIA protein] |
CTD |
PMID:30821613 |
|
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
|
|
G |
Lat2 |
linker for activation of T cells family, member 2 |
increases response to substance |
ISO |
LAT2 protein results in increased susceptibility to Chloroquine |
CTD |
PMID:32587277 |
|
NCBI chr 5:134,628,957...134,648,637
Ensembl chr 5:134,628,876...134,643,879
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
ISO |
Chloroquine results in increased expression of LCN2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions |
EXP |
Chloroquine affects the reaction [SORT1 protein affects the reaction [LDLR protein affects the abundance of Cholesterol]] |
CTD |
PMID:30950489 |
|
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of LEP protein] |
CTD |
PMID:22341560 |
|
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lepr |
leptin receptor |
increases expression |
EXP |
Chloroquine results in increased expression of LEPR protein |
CTD |
PMID:31199479 |
|
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Ltb |
lymphotoxin B |
increases expression |
ISO |
Chloroquine results in increased expression of LTB |
CTD |
PMID:15139008 |
|
NCBI chr17:35,413,483...35,415,281
Ensembl chr17:35,413,415...35,415,296
|
|
G |
M6pr |
mannose-6-phosphate receptor, cation dependent |
affects expression affects localization |
ISO |
Chloroquine affects the expression of M6PR mRNA Chloroquine affects the localization of M6PR protein |
CTD |
PMID:15712280 PMID:29940786 |
|
NCBI chr 6:122,285,679...122,294,639
Ensembl chr 6:122,285,679...122,294,639
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
increases expression multiple interactions |
ISO EXP |
Chloroquine results in increased expression of MAP1LC3A protein; Chloroquine results in increased expression of MAP1LC3A protein modified form Chloroquine inhibits the reaction [doramectin results in decreased expression of and results in increased lipidation of MAP1LC3A protein]; Chloroquine inhibits the reaction [doramectin results in decreased expression of MAP1LC3A protein] Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3A protein] Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein] |
CTD |
PMID:30280407 PMID:30871063 PMID:35137919 PMID:35302183 PMID:35843418 |
|
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression decreases degradation increases lipidation multiple interactions affects localization increases cleavage |
ISO EXP |
Chloroquine results in increased expression of MAP1LC3B mRNA; Chloroquine results in increased expression of MAP1LC3B protein; Chloroquine results in increased expression of MAP1LC3B protein modified form Chloroquine results in decreased degradation of MAP1LC3B protein modified form Chloroquine results in increased lipidation of MAP1LC3B protein Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]]; Chloroquine promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [erastin results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [trichostatin A results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [Vorinostat results in increased expression of MAP1LC3B protein modified form] Chloroquine affects the localization of MAP1LC3B protein Chloroquine results in increased cleavage of MAP1LC3B protein [Ethanol co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein; Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein]; Chloroquine inhibits the reaction [VCP protein mutant form results in decreased expression of MAP1LC3B protein]; Chloroquine promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased lipidation of MAP1LC3B protein]; MJN110 affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein] [4-nitrochalcone co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein; [Chloroquine co-treated with Clozapine] results in increased lipidation of MAP1LC3B protein; [Chloroquine co-treated with flavokawain B] results in increased expression of MAP1LC3B protein modified form; [Chloroquine co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein; [Chloroquine co-treated with TNF protein] results in increased expression of MAP1LC3B protein alternative form; bafilomycin A1 inhibits the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; Chloroquine affects the reaction [dorsomorphin results in increased lipidation of MAP1LC3B protein]; Chloroquine affects the reaction [NDRG1 protein affects the lipidation of MAP1LC3B protein]; Chloroquine inhibits the reaction [cordycepin results in increased expression of MAP1LC3B mRNA]; Chloroquine inhibits the reaction [ovatodiolide results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [1-Methyl-4-phenylpyridinium results in increased lipidation of and results in increased localization of MAP1LC3B protein]; Chloroquine promotes the reaction [4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline affects the localization of MAP1LC3B protein]; Chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [[Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form]; Chloroquine promotes the reaction [ABBV-744 results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [ABBV-744 results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein]; Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [Ethanol results in increased expression of MAP1LC3B protein]; Chloroquine promotes the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [fosbretabulin results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]]; Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [pectolinarigenin results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [Rifampin results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [SC-66 compound results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [sepantronium results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [sodium arsenite results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [TNF protein results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Chloroquine results in increased expression of and results in increased lipidation of MAP1LC3B protein; Chloroquine results in increased lipidation of and results in increased cleavage of MAP1LC3B protein; cryptotanshinone promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein]; CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form]; GAL3ST1 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; Hydrogen Peroxide inhibits the reaction [Chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]]; NDRG1 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; NOD2 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; olaparib promotes the reaction [Chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]]; olaparib promotes the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; Paraquat inhibits the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form]; PARP1 protein affects the reaction [Chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]]; pectolinarigenin promotes the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; TNF protein promotes the reaction [Chloroquine results in increased expression of and results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:17643062 PMID:23880069 PMID:24095927 PMID:24145604 PMID:24161432 PMID:24492484 PMID:25412314 PMID:25884947 PMID:26409479 PMID:28275691 PMID:28600121 PMID:28722353 PMID:28906492 PMID:29248574 PMID:29476062 PMID:30025493 PMID:30208301 PMID:30237538 PMID:30301768 PMID:30338810 PMID:31310755 PMID:31586597 PMID:31648047 PMID:31837377 PMID:31862506 PMID:31900833 PMID:32861759 PMID:32937103 PMID:33203845 PMID:33609687 PMID:34826546 PMID:35104487 PMID:35843418 PMID:36070022 PMID:36078115 PMID:36299321 PMID:36482696 PMID:36958258 PMID:37148176 PMID:37393350 PMID:37466199 PMID:37741534 PMID:37769529 PMID:37939893 PMID:38000454 More...
|
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] |
CTD |
PMID:26676567 |
|
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK1 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK1 protein]] Chloroquine results in decreased phosphorylation of MAPK1 protein [Chloroquine co-treated with Cannabidiol] affects the phosphorylation of MAPK1 protein; Chloroquine affects the reaction [Cannabidiol affects the phosphorylation of MAPK1 protein] Chloroquine results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:18055026 PMID:22341560 PMID:28134560 PMID:31310755 PMID:32060308 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [hydroquinone results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:35302183 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
increases phosphorylation decreases phosphorylation multiple interactions |
ISO EXP |
Chloroquine results in increased phosphorylation of MAPK3 protein Chloroquine results in decreased phosphorylation of MAPK3 protein [Chloroquine co-treated with Cannabidiol] affects the phosphorylation of MAPK3 protein; Chloroquine affects the reaction [Cannabidiol affects the phosphorylation of MAPK3 protein] Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK3 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:18055026 PMID:22341560 PMID:28134560 PMID:31310755 PMID:32060308 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP ISO |
Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK8 protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK8 protein]] Chloroquine inhibits the reaction [Rifampin inhibits the reaction [Rotenone results in increased phosphorylation of MAPK8 protein]]; Chloroquine promotes the reaction [Rotenone results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:22341560 PMID:28134560 PMID:31648047 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapt |
microtubule-associated protein tau |
affects expression multiple interactions |
ISO |
Chloroquine affects the expression of MAPT mRNA; Chloroquine affects the expression of MAPT protein Chloroquine inhibits the reaction [Sertraline results in decreased expression of and results in decreased cleavage of MAPT protein] Chloroquine affects the localization of and affects the degradation of MAPT protein |
CTD |
PMID:9690670 PMID:33124469 |
|
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [usnic acid results in decreased expression of MCL1 protein] |
CTD |
PMID:25078063 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Mir155 |
microRNA 155 |
multiple interactions |
ISO |
[Carboplatin co-treated with Chloroquine] results in increased expression of MIR155 mRNA |
CTD |
PMID:27692344 |
|
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
|
|
G |
Mir224 |
microRNA 224 |
|
ISO |
inhibits the reaction [Amiodarone decreased expression of miR224 in a human hepatoma cell line] |
RGD |
PMID:23913306 |
RGD:18182923 |
NCBI chr X:71,304,637...71,304,718
Ensembl chr X:71,304,637...71,304,718
|
|
G |
Mir669n |
microRNA 669n |
multiple interactions |
EXP |
[Lipopolysaccharides co-treated with Chloroquine] results in decreased expression of MIR669N mRNA |
CTD |
PMID:26807181 |
|
NCBI chr 3:115,773,551...115,773,604
Ensembl chr 3:115,773,551...115,773,604
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
multiple interactions |
ISO EXP |
[Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein [Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]] |
CTD |
PMID:30025493 PMID:30482226 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions increases expression |
EXP ISO |
Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of MMP13 mRNA]; Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased secretion of MMP13 protein] Chloroquine results in increased expression of MMP13 mRNA; Chloroquine results in increased expression of MMP13 protein Oxygen deficiency promotes the reaction [Chloroquine results in increased expression of MMP13 mRNA]; TLR9 protein promotes the reaction [Oxygen deficiency promotes the reaction [Chloroquine results in increased expression of MMP13 mRNA]] |
CTD |
PMID:23331101 PMID:24273604 |
|
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions |
ISO |
Chloroquine results in decreased expression of MMP2 mRNA; Chloroquine results in decreased expression of MMP2 protein Chloroquine inhibits the reaction [cordycepin results in decreased activity of MMP2 protein]; Chloroquine inhibits the reaction [cordycepin results in decreased expression of MMP2 mRNA]; Sirolimus inhibits the reaction [Chloroquine results in decreased expression of MMP2 protein] |
CTD |
PMID:24273604 PMID:34278709 PMID:36299321 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression increases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; Oxygen deficiency inhibits the reaction [Chloroquine results in decreased expression of MMP9 mRNA] Chloroquine results in decreased expression of MMP9 mRNA; Chloroquine results in decreased expression of MMP9 protein Chloroquine results in increased expression of MMP9 mRNA |
CTD |
PMID:24145604 PMID:24273604 PMID:30551460 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mterf3 |
mitochondrial transcription termination factor 3 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MTERF3 protein]; Chloroquine inhibits the reaction [Cycloheximide results in decreased expression of MTERF3 protein] |
CTD |
PMID:35904214 |
|
NCBI chr13:67,053,520...67,081,148
Ensembl chr13:67,055,032...67,081,152
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions increases expression decreases phosphorylation |
ISO EXP |
Chloroquine inhibits the reaction [formosanin C results in decreased phosphorylation of MTOR protein] Chloroquine results in increased expression of MTOR protein Chloroquine results in decreased phosphorylation of MTOR protein |
CTD |
PMID:25884947 PMID:27180204 PMID:31310755 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions increases expression |
ISO EXP |
[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Chloroquine] results in increased expression of MTTP protein Chloroquine results in increased expression of MTTP protein |
CTD |
PMID:34516972 |
|
NCBI chr 3:137,795,616...137,849,179
Ensembl chr 3:137,795,615...137,850,729
|
|
G |
Muc1 |
mucin 1, transmembrane |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [MUC1 affects the expression of EGFR protein] |
CTD |
PMID:22457794 |
|
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Myd88 |
myeloid differentiation primary response gene 88 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MYD88 mRNA] |
CTD |
PMID:22341560 |
|
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
|
|
G |
Myom2 |
myomesin 2 |
increases expression |
ISO |
Chloroquine results in increased expression of MYOM2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 8:15,107,653...15,183,410
Ensembl chr 8:15,107,653...15,183,541
|
|
G |
Nacc1 |
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
multiple interactions |
ISO |
Chloroquine affects the reaction [NACC1 affects the susceptibility to Cisplatin] |
CTD |
PMID:21743489 |
|
NCBI chr 8:85,397,106...85,414,528
Ensembl chr 8:85,397,108...85,414,531
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
increases expression multiple interactions |
ISO |
Chloroquine results in increased expression of NCOA4 mRNA; Chloroquine results in increased expression of NCOA4 protein Chloroquine inhibits the reaction [erastin results in decreased expression of NCOA4 protein] Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]; Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA]; Chloroquine inhibits the reaction [Particulate Matter results in increased expression of NCOA4 protein] |
CTD |
PMID:30551460 PMID:32937103 PMID:36482696 PMID:36700298 PMID:37951334 |
|
NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812
|
|
G |
Ndrg1 |
N-myc downstream regulated gene 1 |
multiple interactions |
ISO |
Chloroquine affects the reaction [NDRG1 protein affects the lipidation of MAP1LC3B protein]; Chloroquine inhibits the reaction [Cycloheximide results in decreased expression of NDRG1 protein]; Chloroquine promotes the reaction [fosbretabulin results in increased expression of NDRG1 protein]; NDRG1 protein affects the reaction [Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of CASP3 protein]]; NDRG1 protein affects the reaction [Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]]; NDRG1 protein affects the reaction [Chloroquine results in increased cleavage of CASP3 protein]; NDRG1 protein affects the reaction [Chloroquine results in increased cleavage of PARP1 protein]; NDRG1 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; NDRG1 protein affects the susceptibility to [fosbretabulin co-treated with Chloroquine] |
CTD |
PMID:28906492 |
|
NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
decreases expression multiple interactions |
ISO EXP |
Chloroquine results in decreased expression of NFKB1 protein Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of NFKB1 protein] |
CTD |
PMID:22341560 PMID:26116531 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO EXP |
[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of NFKBIA protein; Chloroquine inhibits the reaction [Bortezomib results in increased degradation of NFKBIA protein]; LAMP2 protein alternative form affects the reaction [[quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of NFKBIA protein] Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of NFKBIA protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of NFKBIA protein]] |
CTD |
PMID:24085292 PMID:28134560 PMID:30821613 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
multiple interactions |
ISO |
NOD2 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:23880069 |
|
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP |
Chloroquine promotes the reaction [sunitinib results in increased expression of NOS2 protein] |
CTD |
PMID:24751611 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Notch1 |
notch 1 |
multiple interactions |
ISO |
[Fluorouracil co-treated with Chloroquine] results in increased expression of NOTCH1 protein |
CTD |
PMID:29917191 |
|
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
|
|
G |
Nppc |
natriuretic peptide type C |
decreases expression |
ISO |
Chloroquine results in decreased expression of NPPC mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 1:86,594,015...86,598,295
Ensembl chr 1:86,594,013...86,598,293
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide quinone reductase 2 |
multiple interactions |
ISO |
Chloroquine binds to and results in decreased activity of NQO2 protein |
CTD |
PMID:15078100 |
|
NCBI chr13:34,148,642...34,172,448
Ensembl chr13:34,148,670...34,172,426
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
EXP |
Chloroquine results in decreased expression of NR0B2 mRNA |
CTD |
PMID:24189133 |
|
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
multiple interactions |
ISO |
Chloroquine binds to and results in increased activity of NR4A2 protein |
CTD |
PMID:31175960 |
|
NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015
|
|
G |
Ocln |
occludin |
increases expression |
ISO |
Chloroquine results in increased expression of OCLN mRNA |
CTD |
PMID:25752684 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Optn |
optineurin |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [VCP protein mutant form results in increased expression of OPTN protein] |
CTD |
PMID:25884947 |
|
NCBI chr 2:5,023,902...5,069,210
Ensembl chr 2:5,025,453...5,068,862
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of OSGIN1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions increases cleavage |
ISO EXP |
Chloroquine promotes the reaction [Cadmium results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [Methamphetamine results in increased cleavage of PARP1 protein] Chloroquine results in increased cleavage of PARP1 protein [Chloroquine co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein; [Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Chloroquine inhibits the reaction [betulin results in increased cleavage of PARP1 protein]; Chloroquine inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [SC-66 compound results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [sodium arsenite results in increased activity of PARP1 protein]; NDRG1 protein affects the reaction [Chloroquine promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]]; NDRG1 protein affects the reaction [Chloroquine results in increased cleavage of PARP1 protein]; PARP1 protein affects the reaction [Chloroquine promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]] |
CTD |
PMID:27658547 PMID:28906492 PMID:29111403 PMID:30025493 PMID:30338810 PMID:30985881 PMID:31310755 PMID:32190974 PMID:34374793 PMID:34826546 PMID:35022897 PMID:36958258 PMID:37741534 More...
|
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Imiquimod results in increased expression of PCNA protein] |
CTD |
PMID:36002070 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pink1 |
PTEN induced putative kinase 1 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PINK1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]] |
CTD |
PMID:33271250 |
|
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
|
|
G |
Plin3 |
perilipin 3 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [CpG ODN 1826 results in increased expression of PLIN3 mRNA]; Chloroquine inhibits the reaction [CpG ODN 1826 results in increased expression of PLIN3 protein] |
CTD |
PMID:20628022 |
|
NCBI chr17:56,585,962...56,597,511
Ensembl chr17:56,584,476...56,599,873
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax] results in increased expression of PMAIP1 protein] |
CTD |
PMID:35561756 |
|
NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
|
|
G |
Pomc |
pro-opiomelanocortin-alpha |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [POMC protein modified form results in increased chemical synthesis of Adrenal Cortex Hormones] |
CTD |
PMID:2993719 |
|
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
|
|
G |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein] |
CTD |
PMID:35302183 |
|
NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
multiple interactions |
ISO |
Chloroquine analog binds to and results in decreased activity of PPT1 protein; Chloroquine binds to and results in decreased activity of PPT1 protein |
CTD |
PMID:30442709 |
|
NCBI chr 4:122,729,879...122,752,968
Ensembl chr 4:122,730,035...122,752,968
|
|
G |
Prkd2 |
protein kinase D2 |
multiple interactions |
ISO |
Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]; Chloroquine affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein] |
CTD |
PMID:37951334 |
|
NCBI chr 7:16,576,827...16,604,386
Ensembl chr 7:16,576,827...16,604,389
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
EXP ISO |
Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PRKN protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PRKN protein]] Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of PRKN protein]] |
CTD |
PMID:33271250 PMID:35104487 |
|
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
|
|
G |
Prlr |
prolactin receptor |
decreases expression |
ISO |
Chloroquine results in decreased expression of PRLR mRNA |
CTD |
PMID:19393257 |
|
NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
|
|
G |
Pten |
phosphatase and tensin homolog |
increases expression |
EXP |
Chloroquine results in increased expression of PTEN mRNA |
CTD |
PMID:31310755 |
|
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Particulate Matter results in increased expression of PTGS2 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] |
CTD |
PMID:24145604 PMID:36700298 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
increases expression |
ISO |
Chloroquine results in increased expression of RBPJ protein |
CTD |
PMID:22302987 |
|
NCBI chr 5:53,713,121...53,814,787
Ensembl chr 5:53,623,494...53,814,704
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions decreases expression increases activity |
ISO EXP |
[Chloroquine co-treated with Cannabidiol] results in decreased phosphorylation of RELA protein; Acetylcysteine inhibits the reaction [Chloroquine results in increased activity of RELA protein]; diphenyliodonium inhibits the reaction [Chloroquine results in increased activity of RELA protein] Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of and affects the localization of RELA protein]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of RELA protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of and affects the localization of RELA protein]] Chloroquine inhibits the reaction [[Diethylnitrosamine co-treated with N-nitrosomorpholine] results in increased expression of RELA protein] Chloroquine results in decreased expression of RELA protein |
CTD |
PMID:15139008 PMID:24990399 PMID:26116531 PMID:28134560 PMID:32060308 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rheb |
Ras homolog enriched in brain |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [EGF protein results in increased expression of RHEB protein] |
CTD |
PMID:22689575 |
|
NCBI chr 5:25,007,821...25,047,359
Ensembl chr 5:25,007,821...25,047,622
|
|
G |
Rhob |
ras homolog family member B |
increases expression |
ISO |
Chloroquine results in increased expression of RHOB protein |
CTD |
PMID:36482696 |
|
NCBI chr12:8,547,661...8,550,009
Ensembl chr12:8,547,661...8,550,009
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
multiple interactions increases expression decreases phosphorylation |
ISO EXP |
Chloroquine inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KB1 protein] Chloroquine results in increased expression of RPS6KB1 protein modified form Chloroquine results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:22689575 PMID:25884947 PMID:31310755 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
Runx2 |
runt related transcription factor 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] |
CTD |
PMID:23111315 |
|
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression multiple interactions |
ISO EXP |
Chloroquine results in decreased expression of SCARB1 mRNA [Chloroquine co-treated with Lovastatin] inhibits the reaction [SCARB1 protein results in increased abundance of Progesterone] |
CTD |
PMID:19393257 PMID:20404351 |
|
NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
|
|
G |
Sccpdh |
saccharopine dehydrogenase (putative) |
decreases expression |
ISO |
Chloroquine results in decreased expression of SCCPDH mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 1:179,495,796...179,514,754
Ensembl chr 1:179,495,775...179,514,754
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of SCD1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
|
|
G |
Senp6 |
SUMO/sentrin specific peptidase 6 |
multiple interactions |
EXP |
[Lipopolysaccharides co-treated with Chloroquine] results in increased expression of SENP6 protein |
CTD |
PMID:26807181 |
|
NCBI chr 9:79,973,862...80,052,064
Ensembl chr 9:79,974,185...80,052,235
|
|
G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
affects localization |
ISO |
Chloroquine affects the localization of SERPINA3 protein |
CTD |
PMID:8616629 |
|
NCBI chr12:104,372,967...104,380,588
Ensembl chr12:104,372,988...104,380,588
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Poly I-C results in increased expression of SERPINE1 mRNA]; Chloroquine inhibits the reaction [Poly I-C results in increased expression of SERPINE1 protein] |
CTD |
PMID:30341573 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Sirt3 |
sirtuin 3 |
increases stability multiple interactions |
ISO |
Chloroquine results in increased stability of SIRT3 mRNA Chloroquine inhibits the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; Chloroquine inhibits the reaction [hydroquinone results in decreased expression of SIRT3 protein] |
CTD |
PMID:35302183 |
|
NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
|
|
G |
Slc12a1 |
solute carrier family 12, member 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of SLC12A1 protein |
CTD |
PMID:22791344 |
|
NCBI chr 2:124,994,430...125,071,922
Ensembl chr 2:124,994,425...125,071,922
|
|
G |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [AVP protein affects the localization of SLC14A2 protein] |
CTD |
PMID:22791344 |
|
NCBI chr18:78,189,359...78,640,165
Ensembl chr18:78,189,363...78,640,157
|
|
G |
Slc19a3 |
solute carrier family 19, member 3 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Chloroquine inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine] |
CTD |
PMID:26528626 |
|
NCBI chr 1:82,990,242...83,016,541
Ensembl chr 1:82,990,244...83,016,169
|
|
G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:27504015 |
|
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:27504015 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
affects localization multiple interactions |
ISO |
Chloroquine affects the localization of SLC2A4 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein]; [[Chloroquine results in increased abundance of Calcium] which affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Chloroquine affects the localization of SLC2A4 protein] which results in increased uptake of Glucose; [Chloroquine results in increased abundance of Calcium] which affects the localization of SLC2A4 protein; gallein inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein] |
CTD |
PMID:27160165 |
|
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
multiple interactions |
EXP ISO |
Chloroquine inhibits the reaction [Cisplatin results in decreased expression of SLC7A11 protein] Chloroquine inhibits the reaction [Particulate Matter results in decreased expression of SLC7A11 protein] |
CTD |
PMID:34302894 PMID:36700298 |
|
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
|
|
G |
Slco1a5 |
solute carrier organic anion transporter family, member 1a5 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:27504015 |
|
NCBI chr 6:142,179,953...142,268,707
Ensembl chr 6:142,179,953...142,268,707
|
|
G |
Snai1 |
snail family zinc finger 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of SNAI1 mRNA] |
CTD |
PMID:30053495 |
|
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions decreases expression |
EXP |
Quercetin inhibits the reaction [Chloroquine results in decreased expression of SOD1 mRNA] |
CTD |
PMID:23607047 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sort1 |
sortilin 1 |
decreases expression multiple interactions |
EXP |
Chloroquine results in decreased expression of SORT1 protein Chloroquine affects the reaction [SORT1 protein affects the reaction [LDLR protein affects the abundance of Cholesterol]] |
CTD |
PMID:25805502 PMID:30950489 |
|
NCBI chr 3:108,191,272...108,268,835
Ensembl chr 3:108,191,398...108,268,827
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax] results in increased expression of SP1 protein] |
CTD |
PMID:35561756 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
ISO EXP |
[Chloroquine co-treated with Oxygen deficiency] results in increased expression of SQSTM1 protein; Chloroquine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [[Simvastatin co-treated with Metformin] results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [[THRA protein co-treated with Triiodothyronine] results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [[venetoclax co-treated with WEHI-539] results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [ABBV-744 results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [ANGPTL8 protein results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Cisplatin results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [cryptotanshinone results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [dactolisib results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [decabromobiphenyl ether results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [doramectin results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [dorsomorphin results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Doxorubicin results in increased degradation of SQSTM1 protein]; Chloroquine inhibits the reaction [formosanin C results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [fosbretabulin results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [hydroquinone results in increased degradation of SQSTM1 protein]; Chloroquine inhibits the reaction [Resveratrol results in increased degradation of SQSTM1 protein]; Chloroquine inhibits the reaction [SC-66 compound results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [sepantronium results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Sorafenib results in decreased expression of SQSTM1 protein]; Chloroquine promotes the reaction [alpha-Chlorohydrin results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [lead acetate results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [ovatodiolide results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [pectolinarigenin results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [sodium arsenite results in increased expression of SQSTM1 protein]; ERGIC3 protein promotes the reaction [Chloroquine results in increased expression of SQSTM1 protein]; pectolinarigenin promotes the reaction [Chloroquine results in increased expression of SQSTM1 protein] Chloroquine inhibits the reaction [cadmium acetate results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Cadmium results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [doramectin results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased expression of SQSTM1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein]; Chloroquine promotes the reaction [Resveratrol promotes the reaction [Glucose results in increased expression of SQSTM1 protein]] [bisphenol A co-treated with Chloroquine] results in increased expression of SQSTM1 protein; Chloroquine affects the reaction [SQSTM1 protein affects the susceptibility to methylmercuric chloride]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]]; Chloroquine inhibits the reaction [Acetaminophen results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [Cadmium Chloride results in decreased expression of SQSTM1 mRNA]; Chloroquine inhibits the reaction [Cadmium Chloride results in decreased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in decreased expression of SQSTM1 protein]]; Chloroquine inhibits the reaction [Sunitinib results in decreased expression of SQSTM1 protein]; Chloroquine promotes the reaction [triethylene glycol dimethacrylate results in increased expression of SQSTM1 protein] |
CTD |
PMID:21858812 PMID:22927544 PMID:23651616 PMID:24262987 PMID:24751611 PMID:25412314 PMID:25884947 PMID:25943029 PMID:27180204 PMID:27588471 PMID:27658547 PMID:28275691 PMID:28600121 PMID:28713934 PMID:28906492 PMID:29222055 PMID:29248574 PMID:29870746 PMID:30208301 PMID:30237538 PMID:30280407 PMID:30338810 PMID:30550853 PMID:30551460 PMID:31586597 PMID:31837377 PMID:31900833 PMID:32186374 PMID:32693121 PMID:32702505 PMID:33070465 PMID:33203845 PMID:33271250 PMID:33462182 PMID:33684387 PMID:34186417 PMID:34405320 PMID:34520793 PMID:34842334 PMID:35104487 PMID:35137919 PMID:35302183 PMID:35561756 PMID:35843418 PMID:36070022 PMID:36078115 PMID:36482696 PMID:36792013 PMID:36958258 PMID:37258240 PMID:37330034 PMID:37393350 PMID:37741534 PMID:37769529 PMID:38000454 More...
|
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Ssb |
small RNA binding exonuclease protection factor La |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [SSB protein results in increased expression of CXCL8 mRNA]; Chloroquine inhibits the reaction [SSB protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:25915936 |
|
NCBI chr 2:69,691,963...69,702,185
Ensembl chr 2:69,691,906...69,702,190
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
ISO |
Chloroquine results in decreased expression of STAR mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
|
|
G |
Stc2 |
stanniocalcin 2 |
decreases expression |
ISO |
Chloroquine results in decreased expression of STC2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
|
|
G |
Strap |
serine/threonine kinase receptor associated protein |
decreases expression |
ISO |
Chloroquine results in decreased expression of STRAP mRNA |
CTD |
PMID:19393257 |
|
NCBI chr 6:137,712,080...137,728,928
Ensembl chr 6:137,712,076...137,728,930
|
|
G |
Syp |
synaptophysin |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Nanotubes, Carbon results in decreased expression of SYP] |
CTD |
PMID:26327526 |
|
NCBI chr X:7,504,819...7,519,495
Ensembl chr X:7,504,710...7,519,495
|
|
G |
Tardbp |
TAR DNA binding protein |
multiple interactions increases expression |
ISO EXP |
Chloroquine promotes the reaction [VCP protein mutant form results in increased expression of TARDBP protein] Chloroquine results in increased expression of TARDBP protein |
CTD |
PMID:25884947 |
|
NCBI chr 4:148,696,839...148,711,672
Ensembl chr 4:148,696,839...148,711,476
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [dorsomorphin results in decreased expression of TET2 mRNA]; Chloroquine inhibits the reaction [dorsomorphin results in decreased expression of TET2 protein] |
CTD |
PMID:31900833 |
|
NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900
|
|
G |
Tgoln1 |
trans-golgi network protein |
affects localization |
ISO |
Chloroquine affects the localization of TGOLN2 protein |
CTD |
PMID:29940786 |
|
NCBI chr 6:72,585,403...72,593,983
Ensembl chr 6:72,585,415...72,593,983
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [[THRA protein co-treated with Triiodothyronine] results in decreased expression of SQSTM1 protein] |
CTD |
PMID:24262987 |
|
NCBI chr11:98,631,539...98,659,832
Ensembl chr11:98,631,464...98,659,832
|
|
G |
Ticam2 |
TIR domain containing adaptor molecule 2 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TICAM2 mRNA] |
CTD |
PMID:22341560 |
|
NCBI chr18:46,691,298...46,707,600
Ensembl chr18:46,690,358...46,707,600
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
multiple interactions decreases expression |
EXP ISO |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TIMP1 protein] Chloroquine results in decreased expression of TIMP1 mRNA Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA] |
CTD |
PMID:22341560 PMID:30551460 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TIMP2 protein] |
CTD |
PMID:22341560 |
|
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
|
|
G |
Tlr3 |
toll-like receptor 3 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Poly I-C results in increased activity of TLR3 protein] |
CTD |
PMID:21398612 |
|
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
Chloroquine promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of TLR4 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tlr7 |
toll-like receptor 7 |
decreases activity |
ISO |
Chloroquine results in decreased activity of TLR7 protein |
CTD |
PMID:27385120 |
|
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
|
|
G |
Tlr8 |
toll-like receptor 8 |
decreases activity |
ISO |
Chloroquine results in decreased activity of TLR8 protein |
CTD |
PMID:27385120 |
|
NCBI chr X:166,024,119...166,047,325
Ensembl chr X:166,025,692...166,047,325
|
|
G |
Tlr9 |
toll-like receptor 9 |
decreases expression multiple interactions increases expression decreases activity |
ISO EXP |
Chloroquine results in decreased expression of TLR9 protein Chloroquine inhibits the reaction [[Diethylnitrosamine co-treated with N-nitrosomorpholine] results in increased expression of TLR9 protein] Chloroquine inhibits the reaction [CpG ODN 2006 results in increased activity of TLR9 protein]; Chloroquine inhibits the reaction [CpG ODN 2395 results in increased activity of TLR9 protein]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TLR9 mRNA]; Oxygen deficiency inhibits the reaction [Chloroquine results in increased expression of TLR9 mRNA]; TLR9 protein promotes the reaction [Oxygen deficiency promotes the reaction [Chloroquine results in increased expression of MMP13 mRNA]] Chloroquine results in decreased activity of TLR9 protein |
CTD |
PMID:21398612 PMID:22595112 PMID:24273604 PMID:24990399 |
|
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tm7sf2 |
transmembrane 7 superfamily member 2 |
decreases expression |
ISO |
Chloroquine results in decreased expression of TM7SF2 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr19:6,112,851...6,117,880
Ensembl chr19:6,112,851...6,118,403
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions decreases secretion increases expression |
ISO EXP |
Chloroquine results in decreased expression of TNF protein Chloroquine inhibits the reaction [3,4-dihydroxyphenylethanol inhibits the reaction [Hydrogen Peroxide results in increased secretion of TNF protein]] [Chloroquine co-treated with TNF protein] results in increased expression of MAP1LC3B protein alternative form; Chloroquine inhibits the reaction [alpinetin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]]; Chloroquine inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; Chloroquine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]; Chloroquine promotes the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form]; Chloroquine promotes the reaction [TNF protein results in increased expression of and results in increased lipidation of MAP1LC3B protein]; TNF protein promotes the reaction [Chloroquine results in increased expression of and results in increased lipidation of MAP1LC3B protein] Chloroquine results in decreased secretion of TNF protein Chloroquine results in increased expression of TNF Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased secretion of TNF protein]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; Chloroquine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TNF protein]]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TNF mRNA]; Chloroquine promotes the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of TNF protein]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]] |
CTD |
PMID:8244452 PMID:9002011 PMID:9799232 PMID:10638776 PMID:15139008 PMID:22341560 PMID:24145604 PMID:26498332 PMID:28134560 PMID:31332898 PMID:31676321 PMID:33609687 PMID:35302183 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
increases expression |
ISO |
Chloroquine results in increased expression of TNFRSF10A protein |
CTD |
PMID:27692344 |
|
NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
|
|
G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [Cadmium Chloride results in increased expression of TNFRSF11A mRNA]; Chloroquine inhibits the reaction [Cadmium Chloride results in increased expression of TNFRSF11A protein] |
CTD |
PMID:35843418 |
|
NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNFRSF1A protein] |
CTD |
PMID:22341560 |
|
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNFRSF1B protein] |
CTD |
PMID:22341560 |
|
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
G |
Tomm20 |
translocase of outer mitochondrial membrane 20 |
multiple interactions |
EXP |
Chloroquine promotes the reaction [Triiodothyronine results in increased expression of TOMM20 protein] |
CTD |
PMID:30209975 |
|
NCBI chr 8:127,657,414...127,672,671
Ensembl chr 8:127,657,417...127,672,594
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression multiple interactions |
ISO EXP |
Chloroquine results in increased expression of TRIB3 protein 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of TRIB3 protein]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [Chloroquine results in increased expression of TRIB3 protein]; [Bortezomib co-treated with Chloroquine] results in increased expression of TRIB3 protein; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Doxorubicin promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of TRIB3 protein]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased expression of TRIB3 protein] 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; [Bortezomib co-treated with Chloroquine] results in increased expression of TRIB3 protein; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Doxorubicin promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of TRIB3 protein]; Doxorubicin promotes the reaction [Chloroquine results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Nitroprusside promotes the reaction [Chloroquine results in increased expression of TRIB3 protein] |
CTD |
PMID:30482226 |
|
NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
|
|
G |
Trim63 |
tripartite motif-containing 63 |
affects expression |
ISO |
Chloroquine affects the expression of TRIM63 mRNA |
CTD |
PMID:19296457 |
|
NCBI chr 4:134,042,431...134,056,940
Ensembl chr 4:134,042,431...134,056,940
|
|
G |
Trp53 |
transformation related protein 53 |
increases activity multiple interactions |
ISO EXP |
Chloroquine results in increased activity of TP53; Chloroquine results in increased activity of TP53 protein Chloroquine inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] TRP53 mutant form inhibits the reaction [Chloroquine results in increased activity of CASP3 protein] |
CTD |
PMID:11589424 PMID:12082016 PMID:18089834 PMID:22927544 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 mRNA]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of TRPC1 protein] |
CTD |
PMID:32956540 |
|
NCBI chr 9:95,587,125...95,632,438
Ensembl chr 9:95,587,135...95,632,428
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
Chloroquine results in increased expression of UBC mRNA |
CTD |
PMID:19296457 |
|
NCBI chr 5:125,463,029...125,467,081
Ensembl chr 5:125,463,029...125,467,266
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
increases expression multiple interactions |
EXP |
Chloroquine results in increased expression of USP2 mRNA Chloroquine promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of USP2 mRNA]; lipopolysaccharide, E coli O55-B5 promotes the reaction [Chloroquine results in increased expression of USP2 mRNA] |
CTD |
PMID:28134560 |
|
NCBI chr 9:43,978,318...44,006,924
Ensembl chr 9:43,978,318...44,006,924
|
|
G |
Usp25 |
ubiquitin specific peptidase 25 |
increases expression multiple interactions |
EXP |
Chloroquine results in increased expression of USP25 mRNA; Chloroquine results in increased expression of USP25 protein [Chloroquine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of USP25 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Chloroquine] results in increased expression of USP25 protein; Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of USP25 mRNA]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [Chloroquine results in increased expression of USP25 mRNA]; USP25 protein affects the reaction [[Chloroquine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of USP25 mRNA]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of IRF3 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of and affects the localization of RELA protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNB1 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK1 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK3 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of MAPK8 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of NFKBIA protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL6 protein]]; USP25 protein affects the reaction [Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]] |
CTD |
PMID:28134560 |
|
NCBI chr16:76,810,573...76,913,671
Ensembl chr16:76,810,594...76,913,668
|
|
G |
Usp28 |
ubiquitin specific peptidase 28 |
increases expression multiple interactions |
EXP |
Chloroquine results in increased expression of USP28 mRNA Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of USP28 mRNA]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [Chloroquine results in increased expression of USP28 mRNA] |
CTD |
PMID:28134560 |
|
NCBI chr 9:48,896,577...48,953,817
Ensembl chr 9:48,896,675...48,953,817
|
|
G |
Usp7 |
ubiquitin specific peptidase 7 |
increases expression multiple interactions |
EXP |
Chloroquine results in increased expression of USP7 mRNA Chloroquine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of USP7 mRNA]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [Chloroquine results in increased expression of USP7 mRNA] |
CTD |
PMID:28134560 |
|
NCBI chr16:8,506,586...8,574,931
Ensembl chr16:8,507,459...8,610,172
|
|
G |
Usp8 |
ubiquitin specific peptidase 8 |
multiple interactions |
ISO |
[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein] |
CTD |
PMID:35022897 |
|
NCBI chr 2:126,549,280...126,601,234
Ensembl chr 2:126,549,248...126,601,217
|
|
G |
Vcp |
valosin containing protein |
multiple interactions |
ISO EXP |
Chloroquine promotes the reaction [VCP protein mutant form results in increased expression of TARDBP protein] Chloroquine inhibits the reaction [VCP protein mutant form results in decreased expression of MAP1LC3B protein]; Chloroquine inhibits the reaction [VCP protein mutant form results in increased expression of OPTN protein] |
CTD |
PMID:25884947 |
|
NCBI chr 4:42,979,964...43,000,507
Ensembl chr 4:42,979,963...43,000,507
|
|
G |
Vsnl1 |
visinin-like 1 |
decreases expression |
ISO |
Chloroquine results in decreased expression of VSNL1 mRNA |
CTD |
PMID:19393257 |
|
NCBI chr12:11,375,258...11,486,579
Ensembl chr12:11,375,243...11,486,614
|
|
G |
Xcl1 |
chemokine (C motif) ligand 1 |
multiple interactions |
EXP |
Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of XCL1 protein] |
CTD |
PMID:22341560 |
|
NCBI chr 1:164,759,216...164,763,094
Ensembl chr 1:164,759,213...164,763,096
|
|
G |
Xpo1 |
exportin 1 |
multiple interactions |
ISO |
Chloroquine promotes the reaction [XPO1 protein binds to BECN1 protein]; Chloroquine promotes the reaction [XPO1 protein binds to YWHAQ protein] |
CTD |
PMID:33070465 |
|
NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,055...23,248,249
|
|
G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta |
multiple interactions |
ISO |
Chloroquine promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein]; Chloroquine promotes the reaction [XPO1 protein binds to YWHAQ protein] |
CTD |
PMID:33070465 |
|
NCBI chr12:21,440,330...21,467,437
Ensembl chr12:21,440,072...21,467,638
|
|
G |
Zfp36 |
zinc finger protein 36 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [hydroquinone results in decreased expression of ZFP36 protein] |
CTD |
PMID:35302183 |
|
NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678
|
|
|
G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
affects expression multiple interactions |
ISO |
Hydroxychloroquine affects the expression of ALPL mRNA Hydroxychloroquine affects the reaction [Simvastatin affects the expression of ALPL mRNA] |
CTD |
PMID:28975700 |
|
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
|
|
G |
Bax |
BCL2-associated X protein |
increases activity multiple interactions |
ISO |
Hydroxychloroquine results in increased activity of BAX protein bafilomycin A1 inhibits the reaction [Hydroxychloroquine results in increased activity of BAX protein] |
CTD |
PMID:12813466 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein] |
CTD |
PMID:36843289 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
ISO |
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Hydroxychloroquine results in increased cleavage of CASP3 protein]; FAS protein affects the reaction [Hydroxychloroquine results in increased activity of CASP3 protein] |
CTD |
PMID:12813466 PMID:16734620 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of CCL2 mRNA |
CTD |
PMID:15139008 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cd14 |
CD14 antigen |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD14 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd19 |
CD19 antigen |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD19 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 7:126,007,620...126,016,401
Ensembl chr 7:126,007,622...126,014,061
|
|
G |
Cd27 |
CD27 antigen |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD27 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 6:125,209,583...125,214,014
Ensembl chr 6:125,209,585...125,213,973
|
|
G |
Cd38 |
CD38 antigen |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD38 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 5:44,026,153...44,069,714
Ensembl chr 5:44,025,895...44,069,717
|
|
G |
Cd3d |
CD3 antigen, delta polypeptide |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD3D mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 9:44,893,067...44,898,350
Ensembl chr 9:44,893,084...44,898,637
|
|
G |
Cd40lg |
CD40 ligand |
decreases expression |
ISO |
Hydroxychloroquine results in decreased expression of CD40LG protein |
CTD |
PMID:28793932 |
|
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CD74 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
ISO |
Hydroxychloroquine results in decreased expression of CFLAR mRNA; Hydroxychloroquine results in decreased expression of CFLAR protein |
CTD |
PMID:16734620 |
|
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of CLDN1 mRNA |
CTD |
PMID:25752684 |
|
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CTLA4 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
Ctsb |
cathepsin B |
multiple interactions affects localization |
ISO EXP |
bafilomycin A1 inhibits the reaction [Hydroxychloroquine affects the localization of CTSB protein] |
CTD |
PMID:12813466 |
|
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CXCL1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of CXCL10 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of CXCL8 mRNA |
CTD |
PMID:15139008 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of CXCL1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
multiple interactions decreases activity |
ISO |
Hydroxychloroquine inhibits the reaction [CYP2D6 protein results in increased metabolism of Metoprolol] Hydroxychloroquine results in decreased activity of CYP2D6 protein |
CTD |
PMID:10848718 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
multiple interactions affects expression |
ISO |
Hydroxychloroquine affects the reaction [Simvastatin affects the expression of DHCR7 mRNA] Hydroxychloroquine affects the expression of DHCR7 mRNA |
CTD |
PMID:28975700 |
|
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of ERN1 protein |
CTD |
PMID:25321315 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
FAS protein affects the reaction [Hydroxychloroquine results in increased activity of CASP3 protein] |
CTD |
PMID:16734620 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
affects expression multiple interactions |
ISO |
Hydroxychloroquine affects the expression of HMGCR mRNA Simvastatin affects the reaction [Hydroxychloroquine affects the expression of HMGCR mRNA] |
CTD |
PMID:28975700 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
increases expression |
EXP ISO |
Hydroxychloroquine results in increased expression of IFIH1 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
increases expression |
ISO EXP |
Hydroxychloroquine results in increased expression of IFIT3 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr19:34,560,519...34,566,382
Ensembl chr19:34,560,931...34,566,131
|
|
G |
Ifnb1 |
interferon beta 1, fibroblast |
increases expression |
ISO EXP |
Hydroxychloroquine results in increased expression of IFNB1 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Imiquimod] results in increased secretion of IL10 protein |
CTD |
PMID:31082466 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il10ra |
interleukin 10 receptor, alpha |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of IL10RA mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 9:45,165,135...45,180,447
Ensembl chr 9:45,165,135...45,180,447
|
|
G |
Il12b |
interleukin 12b |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of IL12B mRNA |
CTD |
PMID:25321315 |
|
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Hydroxychloroquine inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of IL1B protein] |
CTD |
PMID:16393772 PMID:32314717 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il23a |
interleukin 23, alpha subunit p19 |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of IL23A mRNA |
CTD |
PMID:25321315 |
|
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO EXP |
[Hydroxychloroquine co-treated with Imiquimod] results in increased secretion of IL6 protein; [Hydroxychloroquine co-treated with ODN2006] results in increased secretion of IL6 protein; Hydroxychloroquine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] Hydroxychloroquine results in increased expression of IL6 mRNA |
CTD |
PMID:9002011 PMID:25321315 PMID:31082466 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf3 |
interferon regulatory factor 3 |
increases expression multiple interactions increases phosphorylation |
EXP ISO |
Hydroxychloroquine results in increased expression of IRF3 mRNA phenyl-N-tert-butylnitrone inhibits the reaction [Hydroxychloroquine results in increased phosphorylation of IRF3 protein] |
CTD |
PMID:25321315 |
|
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Irf4 |
interferon regulatory factor 4 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of IRF4 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of IRF7 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
|
|
G |
Itk |
IL2 inducible T cell kinase |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of ITK mRNA |
CTD |
PMID:28863153 |
|
NCBI chr11:46,215,975...46,280,342
Ensembl chr11:46,215,977...46,280,342
|
|
G |
Jchain |
immunoglobulin joining chain |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of JCHAIN mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 5:88,667,663...88,675,667
Ensembl chr 5:88,667,668...88,675,750
|
|
G |
Jun |
jun proto-oncogene |
increases phosphorylation multiple interactions |
ISO |
Hydroxychloroquine results in increased phosphorylation of JUN protein phenyl-N-tert-butylnitrone inhibits the reaction [Hydroxychloroquine results in increased phosphorylation of JUN protein] |
CTD |
PMID:25321315 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
multiple interactions |
ISO |
[Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein] which results in decreased export of Potassium; Hydroxychloroquine binds to and results in decreased activity of KCNH2 protein |
CTD |
PMID:34058295 |
|
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
|
|
G |
Lck |
lymphocyte protein tyrosine kinase |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of LCK mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 4:129,442,142...129,467,415
Ensembl chr 4:129,442,137...129,467,434
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
increases expression multiple interactions |
EXP ISO |
Hydroxychloroquine results in increased expression of MAVS mRNA Hydroxychloroquine results in increased expression of MAVS mRNA; Hydroxychloroquine results in increased expression of MAVS protein phenyl-N-tert-butylnitrone inhibits the reaction [Hydroxychloroquine results in increased expression of MAVS protein] |
CTD |
PMID:25321315 |
|
NCBI chr 2:131,075,445...131,089,945
Ensembl chr 2:131,075,983...131,089,945
|
|
G |
Mmp1b |
matrix metallopeptidase 1b (interstitial collagenase) |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of MMP1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
Sirolimus inhibits the reaction [Hydroxychloroquine results in decreased expression of MMP2 protein] Hydroxychloroquine results in decreased expression of MMP2 mRNA; Hydroxychloroquine results in decreased expression of MMP2 protein |
CTD |
PMID:34278709 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of MS4A1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr19:11,227,043...11,243,513
Ensembl chr19:11,227,039...11,243,605
|
|
G |
Mvp |
major vault protein |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of MVP mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 7:126,586,036...126,613,729
Ensembl chr 7:126,586,032...126,613,793
|
|
G |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
affects expression |
ISO |
Hydroxychloroquine affects the expression of NFATC1 protein |
CTD |
PMID:28793932 |
|
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
|
|
G |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
affects localization |
ISO |
Hydroxychloroquine affects the localization of NFATC2 protein |
CTD |
PMID:28793932 |
|
NCBI chr 2:168,318,330...168,443,900
Ensembl chr 2:168,318,330...168,443,577
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
increases degradation multiple interactions |
ISO |
Hydroxychloroquine results in increased degradation of NFKBIA protein phenyl-N-tert-butylnitrone inhibits the reaction [Hydroxychloroquine results in increased degradation of NFKBIA protein] |
CTD |
PMID:25321315 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:16393772 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Ocln |
occludin |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of OCLN mRNA |
CTD |
PMID:25752684 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein] |
CTD |
PMID:36843289 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
multiple interactions |
ISO |
Hydroxychloroquine binds to and results in decreased activity of PPT1 protein |
CTD |
PMID:30442709 |
|
NCBI chr 4:122,729,879...122,752,968
Ensembl chr 4:122,730,035...122,752,968
|
|
G |
Prdm1 |
PR domain containing 1, with ZNF domain |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of PRDM1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
|
|
G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of RASGRP1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 2:117,110,464...117,173,358
Ensembl chr 2:117,110,474...117,173,482
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
increases expression |
ISO |
Hydroxychloroquine results in increased expression of RELA protein |
CTD |
PMID:25321315 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rigi |
RNA sensor RIG-I |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of RIGI mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 4:40,203,775...40,239,843
Ensembl chr 4:40,203,773...40,239,828
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
ISO EXP |
Hydroxychloroquine results in increased expression of RSAD2 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr12:26,492,742...26,506,451
Ensembl chr12:26,492,745...26,506,451
|
|
G |
Sdc1 |
syndecan 1 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of SDC1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [Poly I-C results in increased expression of SERPINE1 mRNA]; Hydroxychloroquine inhibits the reaction [Poly I-C results in increased expression of SERPINE1 protein] |
CTD |
PMID:30341573 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Slamf7 |
SLAM family member 7 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of SLAMF7 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr 1:171,458,506...171,480,522
Ensembl chr 1:171,459,971...171,480,603
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
ISO EXP |
Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]] Hydroxychloroquine results in increased expression of SQSTM1 protein [Dronabinol co-treated with Hydroxychloroquine] results in increased expression of SQSTM1 protein; [HU 211 co-treated with Hydroxychloroquine] results in increased expression of SQSTM1 protein |
CTD |
PMID:29426000 PMID:32773031 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Tlr7 |
toll-like receptor 7 |
decreases expression |
ISO |
Hydroxychloroquine results in decreased expression of TLR7 protein |
CTD |
PMID:22513098 |
|
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
|
|
G |
Tlr9 |
toll-like receptor 9 |
decreases expression multiple interactions |
ISO EXP |
Hydroxychloroquine results in decreased expression of TLR9 protein Hydroxychloroquine inhibits the reaction [Fluorouracil results in increased secretion of TLR9 protein] |
CTD |
PMID:22513098 PMID:32314717 |
|
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNF mRNA; Hydroxychloroquine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Hydroxychloroquine results in increased expression of TNF mRNA |
CTD |
PMID:9002011 PMID:25321315 PMID:28863153 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf17 |
tumor necrosis factor receptor superfamily, member 17 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr16:11,131,131...11,137,938
Ensembl chr16:11,131,676...11,137,938
|
|
G |
Traf3 |
TNF receptor-associated factor 3 |
increases expression |
ISO EXP |
Hydroxychloroquine results in increased expression of TRAF3 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr12:111,132,799...111,233,589
Ensembl chr12:111,132,804...111,233,587
|
|
G |
Traf6 |
TNF receptor-associated factor 6 |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of TRAF6 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
|
|
G |
Trim21 |
tripartite motif-containing 21 |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of TRIM21 mRNA |
CTD |
PMID:25321315 |
|
NCBI chr 7:102,207,127...102,214,689
Ensembl chr 7:102,207,128...102,214,693
|
|
G |
Txnip |
thioredoxin interacting protein |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]] |
CTD |
PMID:29426000 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
G |
Uxt |
ubiquitously expressed prefoldin like chaperone |
increases expression |
EXP |
Hydroxychloroquine results in increased expression of UXT mRNA |
CTD |
PMID:25321315 |
|
NCBI chr X:20,818,162...20,828,259
Ensembl chr X:20,807,961...20,828,256
|
|
G |
Vcl |
vinculin |
multiple interactions |
ISO |
Hydroxychloroquine inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of VCL protein] |
CTD |
PMID:28975700 |
|
NCBI chr14:20,979,436...21,083,744
Ensembl chr14:20,979,466...21,083,744
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
ISO |
[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of XBP1 mRNA |
CTD |
PMID:28863153 |
|
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
|
|